Metabolic engineering of microorganisms: general strategies and drug production.
about
Synthetic biology for pharmaceutical drug discoveryTowards a carbon-negative sustainable bio-based economy.Engineering microbial factories for synthesis of value-added productsMicrobial production of vitamin B12: a review and future perspectivesTranscriptome analysis of parallel-evolved Escherichia coli strains under ethanol stress.BglBrick vectors and datasheets: A synthetic biology platform for gene expression.Genome-based characterization of two prenylation steps in the assembly of the stephacidin and notoamide anticancer agents in a marine-derived Aspergillus spTools for metabolic engineering in StreptomycesAn inverse metabolic engineering approach for the design of an improved host platform for over-expression of recombinant proteins in Escherichia coli.A bacterial platform for fermentative production of plant alkaloidsSynthetic biology for therapeutic applications.PSAMM: A Portable System for the Analysis of Metabolic Models.Production of extracellular fatty acid using engineered Escherichia coliEngineering antibiotic production and overcoming bacterial resistance.Metabolic engineering for the production of clinically important molecules: Omega-3 fatty acids, artemisinin, and taxol.Genome-scale metabolic model in guiding metabolic engineering of microbial improvement.Composite polymer-bioceramic scaffolds with drug delivery capability for bone tissue engineering.In vitro production of alkaloids: Factors, approaches, challenges and prospectsGenetic and metabolic engineering of microorganisms for the development of new flavor compounds from terpenic substrates.2-Keto acids based biosynthesis pathways for renewable fuels and chemicals.Enhanced production of nargenicin A1 and creation of a novel derivative using a synthetic biology platform.Enhanced production of nargenicin A(1) and generation of novel glycosylated derivatives.The Need for Integrated Approaches in Metabolic Engineering.Metabolic engineering with systems biology tools to optimize production of prokaryotic secondary metabolites.Biogenesis of antibiotics-viewing its history and glimpses of the future.Genome editing approaches: manipulating of lovastatin and taxol synthesis of filamentous fungi by CRISPR/Cas9 system.Engineering microbial cells for the biosynthesis of natural compounds of pharmaceutical significance.13C-Metabolic Flux Analysis: An Accurate Approach to Demystify Microbial Metabolism for Biochemical Production.Systems metabolic engineering, industrial biotechnology and microbial cell factories.Linking genotype and phenotype of Saccharomyces cerevisiae strains reveals metabolic engineering targets and leads to triterpene hyper-producers.Synergizing 13C Metabolic Flux Analysis and Metabolic Engineering for Biochemical Production.Generate a bioactive natural product library by mining bacterial cytochrome P450 patterns.Kinetic analysis of cytochrome P450 reductase from Artemisia annua reveals accelerated rates of NADH-dependent flavin reduction.Enhanced (S)-linalool production by fusion expression of farnesyl diphosphate synthase and linalool synthase in Saccharomyces cerevisiae.Entraining synthetic genetic oscillators.Improved NADPH supply for xylitol production by engineered Escherichia coli with glycolytic mutations.Bench-top fermentative production of plant benzylisoquinoline alkaloids using a bacterial platform.
P2860
Q26775582-7D714A92-3677-41B3-8A9A-D4BED63B42C2Q28683082-A2C017DF-016F-4CCC-819E-B94DACC4BB52Q28742251-8ADD7D96-C355-47EF-9D53-2157E76A3F8AQ28817816-24762BFE-26BA-499E-BC7F-8E2225D04965Q33721504-F3D51C2B-7D4E-4967-835E-E8E6A167D42AQ34024567-227AEB83-C916-450E-8AFE-AA4E6A85A717Q34132115-EBF3FA83-C5F3-485C-A380-6CD5C1E211C3Q34142945-CDAFABE7-2B81-42A2-B82B-7D499C45A09AQ34324640-269FF216-5791-49D1-9F02-E295941B636CQ35038934-2B9165A9-B85E-48C2-B4BA-E0CD138E06F3Q35057524-3427D690-541E-4A4C-8A1F-84CEEEB271BBQ35909423-63D706CE-0B0E-4E92-A8A3-DA0C89BEB9AEQ36192540-991F672C-C752-4671-859B-983960080142Q37887690-095BAB66-6A19-4197-82F8-70796B6CA0DDQ37948715-79AF3443-3E98-4383-B080-200EAEB628A4Q38063161-F2835EBB-7417-4F59-8C4C-3BE01551BDE2Q38115348-09BE421D-900B-45D9-ADD5-4ACC6A48C97CQ38127172-88DF6781-5399-4158-9ED8-3D793D46F17FQ38185082-4CA4514C-9AFB-418A-8379-D7C4C8FFCACFQ38271419-E27A4E3C-F5AB-4949-B376-E1577AAB6886Q38412598-73541A0D-72E4-45F0-BE42-3216807219D7Q38429805-0556379B-2FDE-43E8-B1B9-0A80AEE3321DQ38801055-CC3CAE39-82F0-471E-A07A-75D22504D5CAQ38807009-4251D870-F8F1-4D99-B7A1-7A9AF8FD37ADQ38836571-13193F7C-E881-4BA0-B777-B1ED8BF47B67Q39227817-14CFED08-6133-4ABC-B129-AA4394220BCEQ40753302-D4873A02-44D1-4F9A-8437-BC0A094108E3Q41704591-73D2E720-7611-4023-AC01-F53E4E7B37AEQ42575388-09F0EE93-4930-47C0-ACC2-D661280B3AD0Q42700824-0B5651D7-A980-4665-8A21-02F090A58FB0Q45057404-CE48322A-E93F-452F-B116-EE2BB53965E8Q45269243-C7D4A375-5C71-44F5-AF06-ACE4C06E79F3Q46964325-A879DC07-1EFB-4703-9B51-C6A8F0429478Q50876658-F0BCE2DD-3F31-493A-96CD-6A327A0E49EDQ51788965-E06E83B3-BB6D-4065-BD45-9B83F832D44FQ53436924-FC828D69-E760-47C8-925D-05782E28B335Q54346022-F41DEF22-3510-4CE3-B3D9-9431EF700DF6
P2860
Metabolic engineering of microorganisms: general strategies and drug production.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metabolic engineering of microorganisms: general strategies and drug production.
@en
Metabolic engineering of microorganisms: general strategies and drug production.
@nl
type
label
Metabolic engineering of microorganisms: general strategies and drug production.
@en
Metabolic engineering of microorganisms: general strategies and drug production.
@nl
prefLabel
Metabolic engineering of microorganisms: general strategies and drug production.
@en
Metabolic engineering of microorganisms: general strategies and drug production.
@nl
P2093
P1433
P1476
Metabolic engineering of microorganisms: general strategies and drug production.
@en
P2093
Jin Hwan Park
Jong Myung Park
Tae Yong Kim
P356
10.1016/J.DRUDIS.2008.08.004
P577
2008-09-18T00:00:00Z